MedTrace Logo

Efficacy and Safety Study of Dexmedetomidine as an Additive to Local Anesthetics in Shoulder Surgery

NCT01557270 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2012-12-04

No results posted yet for this study

Summary

The purpose of this study is to test the efficacy and safety of dexmedetomidine added to ropivacaine in patients undergoing shoulder surgery.

Conditions

  • Drug Safety
  • Self Efficacy

Interventions

DRUG

dexmedetomidine

ropivacaine 100 mg + 150 mcg dexmedetomidine, single shot perineural application

DRUG

saline

ropivacaine + saline placebo, single shot perineural application

Sponsors & Collaborators

  • Prof. Peter Gerner, M.D.

    lead OTHER

Principal Investigators

  • Peter Gerner, MD · Paracelsus Medical University Salzburg, Department of Anesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01557270 on ClinicalTrials.gov